US Patent Issued to Sarepta Therapeutics on May 13 for "Phosphorodiamidate morpholino oligomers" (Massachusetts Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,219, issued on May 13, was assigned to Sarepta Therapeutics Inc. (Cambridge, Mass.).

"Phosphorodiamidate morpholino oligomers" was invented by Baozhong Cai (Cambridge, Mass.), Mitchell Martini (Cambridge, Mass.), Katie Thomas (Cambridge, Mass.) and Ross Shimabuku (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomer synthesis while maintaining overall yield and purity of a synthesized oligomer."

The patent was filed on June 15, 2022, under Application No. 17/841,185.

*...